BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35191019)

  • 1. Cardiovascular disease in hereditary haemophilia: The challenges of longevity.
    Shapiro S; Benson G; Evans G; Harrison C; Mangles S; Makris M
    Br J Haematol; 2022 May; 197(4):397-406. PubMed ID: 35191019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease (CVD) in Canadians with haemophilia: Age-Related CVD in Haemophilia Epidemiological Research (ARCHER study).
    Minuk L; Jackson S; Iorio A; Poon MC; Dilworth E; Brose K; Card R; Rizwan I; Chin-Yee B; Louzada M
    Haemophilia; 2015 Nov; 21(6):736-41. PubMed ID: 26222883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management of older persons with haemophilia.
    Hermans C; de Moerloose P; Dolan G
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):197-206. PubMed ID: 23953685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to compare cardiovascular disease and risk factors in elderly patients with haemophilia with the general population.
    Berger K; Schopohl D; Lowe G; Holme PA; Tait RC; Combescure C; Rauchensteiner S; Klamroth R
    Haemophilia; 2016 Sep; 22(5):e406-16. PubMed ID: 27650262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease prevalence and relevance in haemophilia: a scoping review.
    Rizwan I; Minuk L; Jackson S; Iorio A
    Haemophilia; 2015 May; 21(3):e156-e166. PubMed ID: 25420604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of comorbidities in haemophilia.
    Kempton CL; Makris M; Holme PA
    Haemophilia; 2021 Feb; 27 Suppl 3():37-45. PubMed ID: 32476243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilia and ageing.
    Shapiro S; Makris M
    Br J Haematol; 2019 Mar; 184(5):712-720. PubMed ID: 30592034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in treating elderly patients with haemophilia: a focus on cardiology.
    Zimmermann R; Staritz P; Huth-Kühne A
    Thromb Res; 2014 Nov; 134 Suppl 1():S48-52. PubMed ID: 24968961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of atherosclerosis in haemophilia - how to balance risk of bleeding with risk of ischaemic events.
    de Raucourt E; Roussel-Robert V; Zetterberg E
    Eur J Haematol; 2015 Feb; 94 Suppl 77():23-9. PubMed ID: 25560791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ageing patient with haemophilia.
    Canaro M; Goranova-Marinova V; Berntorp E
    Eur J Haematol; 2015 Feb; 94 Suppl 77():17-22. PubMed ID: 25560790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.
    Nagao A; Suzuki N; Takedani H; Yamasaki N; Chikasawa Y; Sawada A; Kanematsu T; Nojima M; Higasa S; Amano K; Fukutake K; Fujii T; Matsushita T; Suzuki T
    Haemophilia; 2019 Jul; 25(4):e223-e230. PubMed ID: 31045306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging clinical concerns in the ageing haemophilia patient.
    Konkle BA; Kessler C; Aledort L; Andersen J; Fogarty P; Kouides P; Quon D; Ragni M; Zakarija A; Ewenstein B
    Haemophilia; 2009 Nov; 15(6):1197-209. PubMed ID: 19686466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cardiovascular disease in aging persons with haemophilia.
    Schutgens REG; Voskuil M; Mauser-Bunschoten EP
    Hamostaseologie; 2017 Aug; 37(3):196-201. PubMed ID: 27966004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
    Sharathkumar AA; Soucie JM; Trawinski B; Greist A; Shapiro AD
    Haemophilia; 2011 Jul; 17(4):597-604. PubMed ID: 21323799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of an ageing haemophilic population.
    Dolan G
    Haemophilia; 2010 Jul; 16 Suppl 5():11-6. PubMed ID: 20590850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors among adult patients with haemophilia.
    Camelo RM; Caram-Deelder C; Duarte BP; de Moura MCB; Costa NCM; Costa IM; Roncal CGP; Vanderlei AM; Guimaraes TMR; Gouw S; Rezende SM; van der Bom J
    Int J Hematol; 2021 Jun; 113(6):884-892. PubMed ID: 33677769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in Europe.
    Schutgens RE; Klamroth R; Pabinger I; Malerba M; Dolan G;
    Haemophilia; 2014 Sep; 20(5):682-6. PubMed ID: 24724839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation therapy in haemophilia. Managing the unknown.
    Schutgens RE; Tuinenburg A; Fischer K; Mauser-Bunschoten EP
    Hamostaseologie; 2013; 33(4):299-304. PubMed ID: 23446851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How we manage cardiovascular disease in patients with hemophilia.
    Franchini M; Focosi D; Mannucci PM
    Haematologica; 2023 Jul; 108(7):1748-1757. PubMed ID: 36700406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey.
    Fogarty PF; Mancuso ME; Kasthuri R; Bidlingmaier C; Chitlur M; Gomez K; Holme PA; James P; Kruse-Jarres R; Mahlangu J; Mingot-Castellano ME; Soni A;
    Haemophilia; 2015 Sep; 21(5):589-97. PubMed ID: 25689278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.